Skip to Main Content

09.10.03 - Maryland Racing Commission - Final Regulations

FINAL ACTION ON REGULATIONS
MARYLAND REGISTER, VOLUME 43, ISSUE 25,
FRIDAY, DECEMBER 9, 2016

Subtitle 10 RACING COMMISSION

09.10.03 Prohibited Acts

Business Regulation Article, §11-210, Annotated Code of Maryland

Notice of Final Action
[16-254-F]

On November 15, 2016, the Maryland Racing Commission adopted amendments to Regulation .01 under COMAR 09.10.03 Prohibited Acts. This action, which was proposed for adoption in 43:20 Md. R. 1113 (September 30, 2016), has been adopted as proposed.

Effective Date: December 19, 2016.

J. MICHAEL HOPKINS
Executive Director

.01 Definitions.
  A. In this chapter, the following terms have the meanings indicated:
  B. Terms Defined.
    (1) Drug.
      (a) (text unchanged)
      (b) “Drug” includes [the] any combination of phenybutazone,[and] flunixin, or ketoprofen if:
        (i) Phenylbutazone is quantitated at more than 0.3 micrograms per milliliter of blood plasma or serum; [and]
        (ii) Flunixin is quantitated at more than 3.0 nanograms per milliliter of blood plasma or serum; and
        (iii) Ketoprofen is quantitated at more than 1.0 nanogram per milliliter of blood plasma or serum.
    (2) — (3) (text unchanged)